← Eichor
Study identifier: NCT07223177 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Condition: SpO2  ·  Sponsor: Masimo Corporation

PhaseNA
Planned participants100
Who can joinAll sexes, 0 Years to 21 Years
Healthy volunteersYes

About this study

The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.

This description comes directly from the study's public registry record.

Talk to the study team

Chelsea Frank  ·  949-297-7000  ·  clinicalresearchdept@masimo.com

Always discuss trial participation with your own doctor first.

Locations (2)

Paradigm Clinical ResearchModesto, California, United StatesRecruiting
Paradigm Clinical ResearchSan Diego, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07223177